Holmusk has built deep partnerships with industry, academic, institutional, and regulatory leaders across the health and life science sectors. We work with partners to drive game-changing innovation in ways that have never before been possible for behavioral health.
Use real-world evidence to improve the probability of R&D success, bring treatments to market faster, and enhance differentiation of commercial products.
Leverage the NLP-derived deep phenotypic patient level data to sub-segments patients and better identify those with unmet need who are most suitable for a clinical trial.
Use longitudinal patient level RWD and advanced analytical methods to tease out underlying disease vs. effect of external stressors and how these factors affect drug response.
Supplement conventional clinical trial analysis methods to inform R&D strategy as well as clinical development.
Evaluate comparative outcomes and track drug effectiveness in real-world settings. Identify unmet needs where novel therapeutics may be able to most improve patient outcomes.
Develop patient-centric endpoints and outcome measures that can elucidate for the first time the differential response to drugs and novel therapeutics.
Combine digital tools and next-generation predictive analytics to improve member engagement, health outcomes, and value of care.
Improve health outcomes with digital self-solutions for mental well-being and chronic disease management. Our tools combine science-backed user experience and disease management principles with our health and analytics expertise.
Inform program design, risk prediction, and quality measurement with our unique analytic approaches. Our proprietary methods enhance population-level risk and patient targeting, for better management of cost of care and outcomes.
Drive care delivery transformation and better outcomes with actionable, clinically meaningful insights.
We put evidence into the care team's hands to guide care at the patient and population-level. Our Management and Supervision Tool (MaST) provides robust analytics to enable clinicians to predict risk, target patients, and allocate resources more effectively.
HolCare EHR+ features built-in measurement-based care (MBC) to facilitate seamless implementation in your practice. MBC has been proven to improve care, increase response to treatment, help clinicians make better decisions, and contribute to better outcomes.
Advance regulatory decision-making and inform health system innovation with real-world data.
Conduct innovative pilot programs to collect real-world data on tech-based interventions for dementia, diabetes, and other disease areas.
Enable groundbreaking research and answer novel questions in pre-clinical research, diagnostics, health economics, and health services research. Head to our Publications section to see more.
Holmusk works with academia globally to conduct and publish research projects in behavioral health, chronic disease, and analytic methods.